Back to Awarded Treatment Trials


Awarded Trial: 97-RC-299-15

Grant ID

97-RC-299-15

Illness

Bipolar Depression

Primary Drug/Intervention

Secretin

Primary Dosage

1.0 mg/kg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Cancelled

Investigator

Cohen

Sample Size

12

Duration of Study Period for Each Subject

2 weeks

Outcome Measurements

YMRS, MADRS, HAM-D, CGI-BP, PANSS

Results

N/A

Publication

N/A

Link

N/A

PI Name

Bruce Cohen

Degree

MD

Center

N/A

Institution

N/A

Address

N/A

City or Town

Belmont

State or Province

MA

Zip or Postal Code

N/A

Country

USA

Email Address

cohenb@mclean.harvard.edu